ELVN · Enliven Therapeutics, Inc. · Debt
$41.52
-0.41 (-0.98%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$3.04B
Shares
73.27M
Volume · Oct 23
2.3M
Avg daily vol (3M)
1.27M
Debt Profile
Completed filing coverage through Jun 11, 2021Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-06-30 | USD 1,510,000 | 10-Q filed 2026-08-05 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
14 filings
14 filers
Visit website
Investor relations